The latest data point for MCD's operating expenses in Q4'25 shows SG&A expenses at $749M USD, with R&D expenses remaining at no data, resulting in total operating expenses of $749M USD for the period ending December 31, 2025. Over the timeframe from Q1'23 to Q4'25, SG&A expenses exhibit a generally stable to moderately increasing trend, starting at $553M USD and peaking at $749M USD, with notable seasonal spikes in Q4 periods (e.g., $731M USD in Q4'23 and $664M USD in Q4'24) likely driven by year-end operational factors, while mid-year quarters show relative declines such as $536M USD in Q3'24; R&D expenses consistently show no data across all quarters, indicating no reported allocation in this category for the stacked bar chart analysis.